The Nanotechnology-based Drug Delivery market refers to the use of nanotechnology to develop innovative drug delivery systems, enabling targeted and controlled release of therapeutic agents. As the Nanotechnology-based Drug Delivery market size is expected to witness significant growth, driven by its growth outlook and market forecast, the industry is poised for substantial industry expansion. The scope of this market encompasses various drug delivery systems, including nanoparticles, liposomes, and dendrimers, which are used to treat a range of diseases, from cancer to cardiovascular disorders. According to recent reports, the current Nanotechnology-based Drug Delivery market size is approximately $4.1 billion. The market is expected to grow at a CAGR of 18.5%, driven by advancements in nanotechnology, increasing demand for targeted therapies, and rising investments in research and development. Key forces shaping the industry include technology shifts, such as the development of new nanomaterials, regulatory frameworks, which are evolving to accommodate the growth of nanotechnology-based products, and competitive intensity, with major players investing heavily in research and development.